Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization

Chiba et al. describe the use of MS2 bacteriophage coat proteins to develop nanocarriers that display the SARS-CoV-2 spike proteins multivalently for vaccine applications. The vaccine elicited high neutralizing antibody titers and protected Syrian hamsters from virus infection after a single immuniz...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shiho Chiba, Steven J. Frey, Peter J. Halfmann, Makoto Kuroda, Tadashi Maemura, Jie E. Yang, Elizabeth R. Wright, Yoshihiro Kawaoka, Ravi S. Kane
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/eccc0e36630d4307b1d6da12b00abf09
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eccc0e36630d4307b1d6da12b00abf09
record_format dspace
spelling oai:doaj.org-article:eccc0e36630d4307b1d6da12b00abf092021-12-02T15:52:54ZMultivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization10.1038/s42003-021-02128-82399-3642https://doaj.org/article/eccc0e36630d4307b1d6da12b00abf092021-05-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-02128-8https://doaj.org/toc/2399-3642Chiba et al. describe the use of MS2 bacteriophage coat proteins to develop nanocarriers that display the SARS-CoV-2 spike proteins multivalently for vaccine applications. The vaccine elicited high neutralizing antibody titers and protected Syrian hamsters from virus infection after a single immunization.Shiho ChibaSteven J. FreyPeter J. HalfmannMakoto KurodaTadashi MaemuraJie E. YangElizabeth R. WrightYoshihiro KawaokaRavi S. KaneNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Shiho Chiba
Steven J. Frey
Peter J. Halfmann
Makoto Kuroda
Tadashi Maemura
Jie E. Yang
Elizabeth R. Wright
Yoshihiro Kawaoka
Ravi S. Kane
Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization
description Chiba et al. describe the use of MS2 bacteriophage coat proteins to develop nanocarriers that display the SARS-CoV-2 spike proteins multivalently for vaccine applications. The vaccine elicited high neutralizing antibody titers and protected Syrian hamsters from virus infection after a single immunization.
format article
author Shiho Chiba
Steven J. Frey
Peter J. Halfmann
Makoto Kuroda
Tadashi Maemura
Jie E. Yang
Elizabeth R. Wright
Yoshihiro Kawaoka
Ravi S. Kane
author_facet Shiho Chiba
Steven J. Frey
Peter J. Halfmann
Makoto Kuroda
Tadashi Maemura
Jie E. Yang
Elizabeth R. Wright
Yoshihiro Kawaoka
Ravi S. Kane
author_sort Shiho Chiba
title Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization
title_short Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization
title_full Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization
title_fullStr Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization
title_full_unstemmed Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization
title_sort multivalent nanoparticle-based vaccines protect hamsters against sars-cov-2 after a single immunization
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/eccc0e36630d4307b1d6da12b00abf09
work_keys_str_mv AT shihochiba multivalentnanoparticlebasedvaccinesprotecthamstersagainstsarscov2afterasingleimmunization
AT stevenjfrey multivalentnanoparticlebasedvaccinesprotecthamstersagainstsarscov2afterasingleimmunization
AT peterjhalfmann multivalentnanoparticlebasedvaccinesprotecthamstersagainstsarscov2afterasingleimmunization
AT makotokuroda multivalentnanoparticlebasedvaccinesprotecthamstersagainstsarscov2afterasingleimmunization
AT tadashimaemura multivalentnanoparticlebasedvaccinesprotecthamstersagainstsarscov2afterasingleimmunization
AT jieeyang multivalentnanoparticlebasedvaccinesprotecthamstersagainstsarscov2afterasingleimmunization
AT elizabethrwright multivalentnanoparticlebasedvaccinesprotecthamstersagainstsarscov2afterasingleimmunization
AT yoshihirokawaoka multivalentnanoparticlebasedvaccinesprotecthamstersagainstsarscov2afterasingleimmunization
AT raviskane multivalentnanoparticlebasedvaccinesprotecthamstersagainstsarscov2afterasingleimmunization
_version_ 1718385605122981888